Morf-057

3 trials 1 recruiting

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

2 Completed trials

1 Sponsors

15 Countries

Phase II

Phase II: 3

Indications tested

Crohn's disease 1

Sponsors using this IMP

Morphic Therapeutic Inc. 3

All trials

3 total

A Phase 2 Study to Evaluate MORF-057 in Adults with Moderately to Severely Active Crohn’s Disease Recruiting

2023-508158-24-00 Phase II 12 countries Morphic Therapeutic Inc.
A Phase 2b Study to Evaluate MORF-057 in Adults with Moderately to Severely Active UC Ended

2022-500953-17-00 Phase II 13 countries Morphic Therapeutic Inc.
A Phase 2a study to evaluate the Efficacy, Safety, and Tolerability of MORF-057 in Ulcerative Colitis Ended

2024-516960-27-00 Phase II 1 country Morphic Therapeutic Inc.

Showing 1–3 of 3 trials

← All drugs A–Z